Mechanisms and therapeutic effectiveness of lactobacilli
Open Access
- 17 November 2015
- journal article
- review article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 69 (3), 187-203
- https://doi.org/10.1136/jclinpath-2015-202976
Abstract
The gut microbiome is not a silent ecosystem but exerts several physiological and immunological functions. For many decades, lactobacilli have been used as an effective therapy for treatment of several pathological conditions displaying an overall positive safety profile. This review summarises the mechanisms and clinical evidence supporting therapeutic efficacy of lactobacilli. We searched Pubmed/Medline using the keyword ‘Lactobacillus’. Selected papers from 1950 to 2015 were chosen on the basis of their content. Relevant clinical and experimental articles that used lactobacilli as therapeutic agents have been included. Applications of lactobacilli include kidney support for renal insufficiency, pancreas health, management of metabolic imbalance, and cancer treatment and prevention. In vitro and in vivo investigations have shown that prolonged lactobacilli administration induces qualitative and quantitative modifications in the human gastrointestinal microbial ecosystem with encouraging perspectives in counteracting pathology-associated physiological and immunological changes. Few studies have highlighted the risk of translocation with subsequent sepsis and bacteraemia following probiotic administration but there is still a lack of investigations on the dose effect of these compounds. Great care is thus required in the choice of the proper Lactobacillus species, their genetic stability and the translocation risk, mainly related to inflammatory disease-induced gut mucosa enhanced permeability. Finally, we need to determine the adequate amount of bacteria to be delivered in order to achieve the best clinical efficacy decreasing the risk of side effects.Keywords
This publication has 172 references indexed in Scilit:
- Antibacterial activity of probiotic candidates for oral healthAnaerobe, 2013
- Kefir-isolatedLactococcus lactissubsp.lactisinhibits the cytotoxic effect ofClostridium difficile in vitroJournal of Dairy Research, 2012
- Antagonistic Action of Lactobacilli and Bifidobacteria in Relation to Staphylococcus aureus and Their Influence on the Immune Response in Cases of Intravaginal Staphylococcosis in MiceProbiotics and Antimicrobial Proteins, 2012
- Lactobacillus jensenii bacteremia and endocarditis after dilatation and curettage: case report and literature reviewInfection, 2011
- The intestinal epithelial barrier in the control of homeostasis and immunityTrends in Immunology, 2011
- Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritisLife Sciences, 2010
- Improvement of constipation and liver function by plant-derived lactic acid bacteria: A double-blind, randomized trialNutrition, 2010
- Persistierende Lactobacillus casei subspecies rhamnosus-Bakteriämie bei einer 14-jährigen Patientin mit akuter myeloischer Leukämie. Eine Kasuistik*Klinische Padiatrie, 1999
- Recurrent Vulvovaginal CandidiasisNew England Journal of Medicine, 1986
- Side effects of chlorhexidine mouth washesEuropean Journal of Oral Sciences, 1971